Brief: Spectral Announces Q2 Results
Aug 13 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL MEDICAL INC - REVENUE FOR THREE-MONTHS ENDED JUNE
30,
2021 WAS $559,000 COMPARED TO $517,000 FOR SAME THREE-MONTH
PERIOD LAST YEAR
* SPECTRAL MEDICAL INC - CONTINUES TO PREPARE FOR A
POTENTIAL
LISTING ON A SENIOR U.S. EXCHANGE
* SPECTRAL MEDICAL INC - QTRLY LOSS PER SHARE $0.010
Source text for Eikon: ID:nGNX8qxZ6Y
Further company coverage: EDT.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%